Expression of IGF-1R, a transmembrane tyrosine kinase receptor of the insulin receptor family, is related to a malignant phenotype, tumor progression, chemoresistance, and unfavorable survival in CRC [128]. This evidence concerns the gene IGF1R and neoplasm.